$36.440
-1.144 (-3.14%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TEVA Prediction & Forecast by Similar Chart Analysis
Alphio's TEVA stock price prediction model matches the current Teva Pharmaceutical Industries Limited.. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $36.36 (-0.23%). The 1-week path is $37.06 (+1.69%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Teva Pharmaceutical Industries Limited.. Stock?
Teva Pharmaceuticals is currently a hold. The stock has seen a significant one-year change of +94.35%, indicating strong past performance. However, the recent RSI of 41.144 suggests it may be approaching oversold territory, and insider selling has increased by 764.83%, which raises concerns about future performance. The forward P/E ratio of 18.2815 indicates reasonable valuation, but mixed earnings results and a recent drop of 2.41% over the last five days suggest caution. Overall, while there are positive catalysts such as analyst upgrades, the risks associated with insider selling and recent earnings performance warrant a hold position for now.
TEVA stock price ended at $36.44 on Friday, after losing -3.14%
Teva Pharmaceutical Industries Limited.. (TEVA) last closed at $36.44, losing -3.14%. These facts feed the 1-day and 1-week TEVA price prediction above.
Analyst Consensus
Teva Pharmaceutical Industries Limited.. (TEVA): 4 buy, 17 hold, 5 sell. Outlook: Sell.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Teva Pharmaceutical Industries Limited.. (TEVA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches TEVA, ranked by similarity.
Seasonality analysis for TEVA
Historically the probability of a positive August return for TEVA is 66.67%. December offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TEVA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $17.33 | $18.21 | $18.96 | -50.02% |
| Sep 2026 | $16.89 | $19.65 | $22.54 | -46.07% |
| Oct 2026 | $16.61 | $19.78 | $22.10 | -45.73% |
| Nov 2026 | $13.54 | $16.24 | $19.03 | -55.43% |
| Dec 2026 | $15.35 | $16.77 | $17.88 | -53.98% |
In 2026, Teva Pharmaceutical Industries Limited.. (TEVA) is projected to range from $13.54 to $22.54.
Teva Pharmaceutical Industries Limited.. 2026 monthly forecast
In Aug 2026, Teva Pharmaceutical Industries Limited.. is projected to average $18.21, with a low of $17.33 and high of $18.96.
In Sep 2026, Teva Pharmaceutical Industries Limited.. is projected to average $19.65, with a low of $16.89 and high of $22.54.
In Oct 2026, Teva Pharmaceutical Industries Limited.. is projected to average $19.78, with a low of $16.61 and high of $22.10.
In Nov 2026, Teva Pharmaceutical Industries Limited.. is projected to average $16.24, with a low of $13.54 and high of $19.03.
In Dec 2026, Teva Pharmaceutical Industries Limited.. is projected to average $16.77, with a low of $15.35 and high of $17.88.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.